Narrative Update • Aug 17
Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Sector Analysis
UpdatedAug 30, 2026
DataAggregated Company Financials
Companies471
- 7D-1.3%
- 3M4.4%
- 1Y-15.1%
- YTD-8.7%
Over the last 7 days, the Healthcare industry has dropped 1.3%, driven by WuXi AppTec declining 3.4%. In contrast, Shenzhen Mindray Bio-Medical Electronics has gained 6.4%. The industry has fallen 15% in the last year. Earnings are forecast to grow by 21% annually.
Sector Valuation and Performance
Has the Chinese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 30 Aug 2026 | CN¥6.0t | CN¥2.3t | CN¥135.7b | 39.3x | 44.1x | 2.6x |
| Tue, 28 Jul 2026 | CN¥5.8t | CN¥2.3t | CN¥136.6b | 36.7x | 42.2x | 2.5x |
| Thu, 25 Jun 2026 | CN¥5.5t | CN¥2.3t | CN¥136.3b | 36.8x | 40.2x | 2.4x |
| Sat, 23 May 2026 | CN¥5.9t | CN¥2.3t | CN¥136.4b | 40.4x | 43.2x | 2.5x |
| Mon, 20 Apr 2026 | CN¥6.3t | CN¥2.3t | CN¥148.2b | 38.3x | 42.3x | 2.7x |
| Wed, 18 Mar 2026 | CN¥6.3t | CN¥2.3t | CN¥147.8b | 38.5x | 42.4x | 2.7x |
| Fri, 13 Feb 2026 | CN¥6.5t | CN¥2.3t | CN¥146.1b | 41.3x | 44.3x | 2.8x |
| Sun, 11 Jan 2026 | CN¥6.8t | CN¥2.3t | CN¥145.1b | 41.1x | 46.6x | 3x |
| Tue, 09 Dec 2025 | CN¥6.5t | CN¥2.3t | CN¥145.1b | 38.9x | 44.9x | 2.9x |
| Thu, 06 Nov 2025 | CN¥6.7t | CN¥2.3t | CN¥143.7b | 40.6x | 46.5x | 2.9x |
| Sat, 04 Oct 2025 | CN¥6.9t | CN¥2.3t | CN¥146.8b | 39.7x | 46.8x | 3x |
| Mon, 01 Sep 2025 | CN¥6.9t | CN¥2.2t | CN¥142.1b | 41.4x | 48.8x | 3.2x |
| Wed, 30 Jul 2025 | CN¥6.8t | CN¥2.2t | CN¥152.6b | 40.3x | 44.4x | 3.1x |
| Fri, 27 Jun 2025 | CN¥5.9t | CN¥2.2t | CN¥150.0b | 35.2x | 39.3x | 2.7x |
| Sun, 25 May 2025 | CN¥5.8t | CN¥2.2t | CN¥150.6b | 34.4x | 38.7x | 2.6x |
| Tue, 22 Apr 2025 | CN¥5.6t | CN¥2.2t | CN¥155.0b | 32x | 36x | 2.5x |
| Thu, 20 Mar 2025 | CN¥5.8t | CN¥2.2t | CN¥154.7b | 33.4x | 37.7x | 2.6x |
| Sat, 15 Feb 2025 | CN¥5.7t | CN¥2.2t | CN¥153.8b | 32.5x | 36.9x | 2.5x |
| Mon, 13 Jan 2025 | CN¥5.2t | CN¥2.2t | CN¥154.7b | 28.7x | 33.7x | 2.3x |
| Wed, 11 Dec 2024 | CN¥6.0t | CN¥2.2t | CN¥153.7b | 34.9x | 38.9x | 2.7x |
| Fri, 08 Nov 2024 | CN¥6.1t | CN¥2.2t | CN¥154.1b | 34.3x | 39.7x | 2.7x |
| Sun, 06 Oct 2024 | CN¥6.1t | CN¥2.2t | CN¥161.8b | 35.2x | 37.5x | 2.7x |
| Tue, 03 Sep 2024 | CN¥4.9t | CN¥2.2t | CN¥162.0b | 27x | 30.2x | 2.2x |
| Thu, 01 Aug 2024 | CN¥5.1t | CN¥2.3t | CN¥166.1b | 28.2x | 31x | 2.3x |
| Sat, 29 Jun 2024 | CN¥5.2t | CN¥2.3t | CN¥165.0b | 28.5x | 31.2x | 2.3x |
| Mon, 27 May 2024 | CN¥5.7t | CN¥2.3t | CN¥167.6b | 30.4x | 34.2x | 2.5x |
| Wed, 24 Apr 2024 | CN¥5.6t | CN¥2.3t | CN¥177.2b | 29.8x | 31.7x | 2.5x |
| Fri, 22 Mar 2024 | CN¥6.0t | CN¥2.3t | CN¥179.5b | 31.1x | 33.5x | 2.6x |
| Sun, 18 Feb 2024 | CN¥5.7t | CN¥2.3t | CN¥179.8b | 27.4x | 31.5x | 2.5x |
| Tue, 16 Jan 2024 | CN¥6.2t | CN¥2.3t | CN¥176.8b | 32.8x | 34.9x | 2.7x |
| Thu, 14 Dec 2023 | CN¥6.6t | CN¥2.3t | CN¥177.1b | 35.6x | 37.5x | 2.9x |
| Sat, 11 Nov 2023 | CN¥6.6t | CN¥2.3t | CN¥177.3b | 35.4x | 37.3x | 2.9x |
| Mon, 09 Oct 2023 | CN¥6.5t | CN¥2.3t | CN¥185.2b | 33x | 34.9x | 2.8x |
| Wed, 06 Sep 2023 | CN¥6.2t | CN¥2.3t | CN¥186.5b | 31.9x | 33.2x | 2.7x |
Price to Earnings Ratio
33.2x
Current Industry PE
- Investors are optimistic on the Chinese Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 44.1x which is higher than its 3-year average PE of 38.5x.
- The industry is trading close to its 3-year average PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 10% per year over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare sector?
| CN Market | 0.70% | |
| Healthcare | -1.29% | |
| Medical Equipment | 0.91% | |
| Pharma | -0.53% | |
| Healthcare Services | -0.62% | |
| Healthtech | -2.25% | |
| Biotech | -3.27% | |
| Life Sciences | -4.94% | |
Industry PE
- Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 37.5x.
- Analysts are expecting annual earnings growth of 16.0%, which is higher than its past year's earnings decline of 2.4% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 108% over the next 5 years.
- This is better than its past earnings decline of 61% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 16% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 300760 Shenzhen Mindray Bio-Medical Electronics | CN¥164.30 | 6.4% +CN¥11.9b | -32.3% | PE25.3x | |
| 300677 Intco Medical Technology | CN¥54.30 | 12.2% +CN¥3.8b | 47.8% | PE30.9x | |
| 600664 Harbin Pharmaceutical Group | CN¥9.00 | 10.2% +CN¥2.1b | 141.9% | PE44.3x | |
| 600436 Zhangzhou Pientzehuang Pharmaceutical | CN¥127.30 | 2.6% +CN¥1.9b | -39.2% | PE40.4x | |
| 600613 Shanghai Shenqi Pharmaceutical Investment Management | CN¥12.40 | 37.8% +CN¥1.8b | 87.6% | PE241.7x |